Conjunctival T-cell Subpopulations in Sjögren's and Non-Sjögren's Patients with Dry Eye
Overview
Authors
Affiliations
Purpose: To examine the conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca (SS-KCS) and non-Sjögren's keratoconjunctivitis sicca (NS-KCS) for evidence of immune-based inflammation.
Methods: Conjunctival biopsy specimens were obtained from 15 patients with SS-KCS and 15 with NS-KCS. Immunohistochemistry was performed on frozen sections to characterize and quantify T-cell subtypes (CD3, CD4, and CD8) and markers of immune activation (major histocompatibility complex [MHC] class II: HLA-DR, HLA-DQ) and inflammation (intercellular adhesion molecule [ICAM]-1). The numbers of cells positive for each marker were counted by two masked observers and averaged.
Results: Conjunctival biopsy specimens from patients with SS-KCS or NS-KCS revealed lymphocytic infiltration and increased immunoreactivity for the markers of inflammation and immune activation. The extent of cellular immunoreactivity did not differ significantly between SS-KCS and NS-KCS tissue samples.
Conclusions: The authors' findings indicate that patients with SS-KCS or NS-KCS have conjunctival inflammation manifested by inflammatory cell infiltrates and upregulation of expression in markers of immune activation. Clinical symptoms of KCS may be more dependent on T-cell activation and resultant inflammation than previously believed. In addition to tear substitutes, anti-inflammatory therapeutics should be investigated for the treatment of KCS.
Vereertbrugghen A, Pizzano M, Cernutto A, Sabbione F, Keitelman I, Aguilar D Proc Natl Acad Sci U S A. 2024; 121(48):e2407648121.
PMID: 39560641 PMC: 11621630. DOI: 10.1073/pnas.2407648121.
Bhandarkar N, Shetty K, Shetty N, Shetty K, Kiran A, Pindipapanahalli N Front Nutr. 2024; 11:1394298.
PMID: 39279894 PMC: 11397303. DOI: 10.3389/fnut.2024.1394298.
Effect of Topical Programmed Death-Ligand1 on Corneal Epithelium in Dry Eye Mouse.
Lee K, Oh S, Bhujel B, Kim C, Lee H, Park J Biomolecules. 2024; 14(1).
PMID: 38254668 PMC: 10812943. DOI: 10.3390/biom14010068.
How does ocular graft-versus-host disease fit under the dry eye umbrella? A review.
Kantor N, Tovar A, Wang T, Galor A Clin Exp Ophthalmol. 2024; 52(2):167-185.
PMID: 38204146 PMC: 10939887. DOI: 10.1111/ceo.14347.
NLRP3 Inflammasome as a Potential Therapeutic Target in Dry Eye Disease.
Zhuang D, Misra S, Mugisho O, Rupenthal I, Craig J Int J Mol Sci. 2023; 24(13).
PMID: 37446038 PMC: 10341612. DOI: 10.3390/ijms241310866.